Ginsenoside Rd attenuates tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after transient forebrain ischemia

Neurochemical Research

Volumn 39, Issue 7, 2014, Pages 1363-1373

  Zhang, Xiao ^a   Shi, Ming ^a   Ye, Ruidong ^b   Wang, Wei ^c   Liu, Xuedong ^a   Zhang, Guangyun ^a   Han, Junliang ^a   Zhang, Yunxia ^a   Wang, Bing ^a   Zhao, Jun ^a   Hui, Juan ^a   Xiong, Lize ^a   Zhao, Gang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Ginsenoside Rd; GSK 3 ; Ischemic stroke; PI3K AKT; Tau phosphorylation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GINSENOSIDE RD; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TAU PROTEIN; GINSENOSIDE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; ONCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; COGNITION; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FOREBRAIN; MALE; MORRIS WATER MAZE TEST; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ISCHEMIC ATTACK, TRANSIENT; METABOLISM; PANAX; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; GINSENOSIDES; GLYCOGEN SYNTHASE KINASE 3; ISCHEMIC ATTACK, TRANSIENT; MALE; ONCOGENE PROTEIN V-AKT; PANAX; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; TAU PROTEINS;

EID: 84904577101     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-014-1321-3     Document Type: Article

References (49)

1. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113(24):e873-e923. doi:10.1161/01.STR.0000223048.70103.F1 (Pubitemid 44313581)
2. Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349(9063):1436-1442. doi:10.1016/S0140-6736(96)07495-8 (Pubitemid 27212192)
3. Leys D, Henon H, Mackowiak-Cordoliani MA, Pasquier F (2005) Poststroke dementia. Lancet Neurol 4(11):752-759. doi:10.1016/S1474-4422(05)70221-0 (Pubitemid 41457291)
4. Liu R, Yuan H, Yuan F, Yang SH (2012) Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke. Neurol Res 34(4):331-337. doi:10.1179/1743132812Y.0000000020
5. Tatemichi TK, Paik M, Bagiella E, Desmond DW, Stern Y, Sano M, Hauser WA, Mayeux R (1994) Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 44(10):1885-1891 (Pubitemid 24319216)
6. de la Torre JC (2004) Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 3(3):184-190. doi:10.1016/S1474-4422(04)00683-0
7. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, Masaki K, Launer L, Markesbery WR (2002) Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci 977:9-23 (Pubitemid 35418132)
8. Zhang Q, Gao T, Luo Y, Chen X, Gao G, Gao X, Zhou Y, Dai J (2012) Transient focal cerebral ischemia/reperfusion induces early and chronic axonal changes in rats: its importance for the risk of Alzheimer's disease. PLoS ONE 7(3):e33722. doi:10.1371/journal.pone.0033722
9. Iwata N, Higuchi M, Saido TC (2005) Metabolism of amyloid-beta peptide and Alzheimer's disease. Pharmacol Ther 108(2):129-148. doi:10.1016/j. pharmthera.2005.03.010 (Pubitemid 41527082)
10. Kanemaru K (2013) Immunotherapy targeting misfolded proteins in neurodegenerative disease. Brain Nerve 65(4):469-474
11. Cleveland DW, Hwo SY, Kirschner MW (1977) Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol 116(2):227-247 (Pubitemid 8215105)
12. Billingsley ML, Kincaid RL (1997) Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 323(Pt 3):577-591 (Pubitemid 27202326)
13. Noble W, Olm V, Takata K, Casey E, Mary O, Meyerson J, Gaynor K, LaFrancois J, Wang L, Kondo T, Davies P, Burns M, Veeranna NR, Dickson D, Matsuoka Y, Ahlijanian M, Lau LF, Duff K (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38(4):555-565 (Pubitemid 36645031)
14. Morioka M, Kawano T, Yano S, Kai Y, Tsuiki H, Yoshinaga Y, Matsumoto J, Maeda T, Hamada J, Yamamoto H, Fukunaga K, Kuratsu J (2006) Hyperphosphorylation at serine 199/202 of tau factor in the gerbil hippocampus after transient forebrain ischemia. Biochem Biophys Res Commun 347(1):273-278. doi:10.1016/j.bbrc.2006.06.096 (Pubitemid 44015674)
15. Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH (2000) Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem 74(4):1587-1595 (Pubitemid 30163980)
16. Engel T, Hernandez F, Avila J, Lucas JJ (2006) Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. J Neurosci 26(19):5083-5090. doi:10.1523/JNEUROSCI.0604-06.2006 (Pubitemid 44315289)
17. Zhu LQ, Wang SH, Liu D, Yin YY, Tian Q, Wang XC, Wang Q, Chen JG, Wang JZ (2007) Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments. J Neurosci 27(45):12211-12220. doi:10.1523/JNEUROSCI.3321-07.2007 (Pubitemid 350085482)
18. Cancino GI, Toledo EM, Leal NR, Hernandez DE, Yevenes LF, Inestrosa NC, Alvarez AR (2008) STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits. Brain 131(Pt 9):2425-2442. doi:10.1093/brain/awn125
19. Radad K, Gille G, Liu L, Rausch WD (2006) Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci 100(3):175-186
20. Liu X, Xia J, Wang L, Song Y, Yang J, Yan Y, Ren H, Zhao G (2009) Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: a randomized, double-blind, placebo-controlled, phase II multicenter trial. Eur J Neurol 16(5):569-575. doi:10.1111/j.1468-1331.2009.02534.x
21. Liu X, Wang L, Wen A, Yang J, Yan Y, Song Y, Ren H, Wu Y, Li Z, Chen W, Xu Y, Li L, Xia J, Zhao G (2012) Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial. Eur J Neurol 19(6):855-863. doi:10.1111/j.1468-1331.2011.03634.x
22. Li XY, Liang J, Tang YB, Zhou JG, Guan YY (2010) Ginsenoside Rd prevents glutamate-induced apoptosis in rat cortical neurons. Clin Exp Pharmacol Physiol 37(2):199-204. doi:10.1111/j.1440-1681.2009.05286.x
23. Ye R, Li N, Han J, Kong X, Cao R, Rao Z, Zhao G (2009) Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons. Neurosci Res 64(3):306-310. doi:10.1016/j.neures.2009.03. 016
24. Ye R, Yang Q, Kong X, Han J, Zhang X, Zhang Y, Li P, Liu J, Shi M, Xiong L, Zhao G (2011) Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats. Neurochem Int 58(3):391-398. doi:10.1016/j.neuint.2010.12.015
25. Ye R, Zhang X, Kong X, Han J, Yang Q, Zhang Y, Chen Y, Li P, Liu J, Shi M, Xiong L, Zhao G (2011) Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia. Neuroscience 178:169-180. doi:10.1016/j.neuroscience.2011.01.007
26. Ye R, Kong X, Yang Q, Zhang Y, Han J, Li P, Xiong L, Zhao G (2011) Ginsenoside rd in experimental stroke: superior neuroprotective efficacy with a wide therapeutic window. Neurotherapeutics 8(3):515-525. doi:10.1007/s13311-011- 0051-3
27. Ye R, Zhao G, Liu X (2013) Ginsenoside Rd for acute ischemic stroke: translating from bench to bedside. Expert Rev Neurother 13(6):603-613. doi:10.1586/ern.13.51
28. Li L, Liu J, Yan X, Qin K, Shi M, Lin T, Zhu Y, Kang T, Zhao G (2011) Protective effects of ginsenoside Rd against okadaic acid-induced neurotoxicity in vivo and in vitro. J Ethnopharmacol 138(1):135-141. doi:10.1016/j.jep.2011. 08.068
29. Li L, Liu Z, Liu J, Tai X, Hu X, Liu X, Wu Z, Zhang G, Shi M, Zhao G (2013) Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A. Neurobiol Dis 54:320-328. doi:10.1016/j.nbd.2013.01.002
30. Liu J, Yan X, Li L, Zhu Y, Qin K, Zhou L, Sun D, Zhang X, Ye R, Zhao G (2012) Ginsennoside rd attenuates cognitive dysfunction in a rat model of Alzheimer's disease. Neurochem Res 37(12):2738-2747. doi:10.1007/s11064-012- 0866-2
31. Bevins RA, Besheer J (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat Protoc 1(3):1306-1311. doi:10.1038/nprot.2006.205
32. Li N, Kong X, Ye R, Yang Q, Han J, Xiong L (2011) Age-related differences in experimental stroke: possible involvement of mitochondrial dysfunction and oxidative damage. Rejuvenation Res 14(3):261-273. doi:10.1089/rej.2010.1115
33. Zhang ZH, Xi GM, Li WC, Ling HY, Qu P, Fang XB (2010) Cyclic-AMP response element binding protein and tau are involved in the neuroprotective mechanisms of nerve growth factor during focal cerebral ischemia/reperfusion in rats. J Clin Neurosci 17(3):353-356. doi:10.1016/j.jocn.2009.07.086
34. Gordon-Krajcer W, Kozniewska E, Lazarewicz JW, Ksiezak-Reding H (2007) Differential changes in phosphorylation of tau at PHF-1 and 12E8 epitopes during brain ischemia and reperfusion in gerbils. Neurochem Res 32(4-5):729-737. doi:10.1007/s11064-006-9199-3 (Pubitemid 46481302)
35. Kumar P, Miller AI, Polverini PJ (2004) p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway. J Biol Chem 279(41):43352-43360. doi:10.1074/jbc.M405777200 (Pubitemid 39372230)
36. Liu RL, Xiong QJ, Shu Q, Wu WN, Cheng J, Fu H, Wang F, Chen JG, Hu ZL (2012) Hyperoside protects cortical neurons from oxygen-glucose deprivation-reperfusion induced injury via nitric oxide signal pathway. Brain Res 1469:164-173. doi:10.1016/j.brainres.2012.06.044
37. Pap M, Cooper GM (1998) Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem 273(32):19929-19932 (Pubitemid 28377539)
38. Gim SA, Sung JH, Shah FA, Kim MO, Koh PO (2013) Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model. Lab Anim Res 29(2):63-69. doi:10.5625/lar.2013.29.2.63
39. Zhu L, Fratiglioni L, Guo Z, Aguero-Torres H, Winblad B, Viitanen M (1998) Association of stroke with dementia, cognitive impairment, and functional disability in the very old: a population-based study. Stroke 29(10):2094-2099 (Pubitemid 28443524)
40. Prencipe M, Ferretti C, Casini AR, Santini M, Giubilei F, Culasso F (1997) Stroke, disability, and dementia: results of a population survey. Stroke 28(3):531-536 (Pubitemid 27118373)
41. Shen H, Wu X, Zhu Y, Sun H (2013) Intravenous administration of achyranthes bidentata polypeptides supports recovery from experimental ischemic stroke in vivo. PLoS ONE 8(2):e57055. doi:10.1371/journal.pone.0057055
42. Zhang X, Yeung PK, McAlonan GM, Chung SS, Chung SK (2013) Transgenic mice over-expressing endothelial endothelin-1 show cognitive deficit with blood-brain barrier breakdown after transient ischemia with long-term reperfusion. Neurobiol Learn Mem 101:46-54. doi:10.1016/j.nlm.2013.01.002
43. Roof RL, Schielke GP, Ren X, Hall ED (2001) A comparison of long-term functional outcome after 2 middle cerebral artery occlusion models in rats. Stroke 32(11):2648-2657 (Pubitemid 33055320)
44. Tatemichi TK, Foulkes MA, Mohr JP, Hewitt JR, Hier DB, Price TR, Wolf PA (1990) Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke 21(6):858-866 (Pubitemid 20209711)
45. Dong DW, Zhang YS, Yang WY, Wang-Qin RQ, Xu AD, Ruan YW (2013) Hyperphosphorylation of tau protein in the ipsilateral thalamus after focal cortical infarction in rats. Brain Res. doi:10.1016/j.brainres.2013.11.004
46. Wada A, Yokoo H, Yanagita T, Kobayashi H (2005) Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J Pharmacol Sci 99(4):307-321 (Pubitemid 41813422)
47. Shi C, Zheng DD, Fang L, Wu F, Kwong WH, Xu J (2012) Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt. Biochim Biophys Acta 1820(4):453-460. doi:10.1016/j.bbagen.2011.12.005
48. Hwang YP, Jeong HG (2010) Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells. Toxicol Appl Pharmacol 242(1):18-28. doi:10.1016/j.taap.2009.09.009
49. Zhang X, Shi M, Bjoras M, Wang W, Zhang G, Han J, Liu Z, Zhang Y, Wang B, Chen J, Zhu Y, Xiong L, Zhao G (2013) Ginsenoside Rd promotes glutamate clearance by up-regulating glial glutamate transporter GLT-1 via PI3K/AKT and ERK1/2 pathways. Front Pharmacol 4:152. doi:10.3389/fphar.2013.00152